Overview Getting potassium levels right for heart failure patients is a balancing act due to changes in medications, diet, and kidney function.…
Overview A s a clinical pharmacist, you'll hear about using IV iron to improve heart failure symptoms. Up to 20% of heart failure patients are…
Introduction L ess than half of eligible heart failure patients take an aldosterone antagonist like spironolactone or eplerenone. Close the gap …
Optimizing oral loop diuretics like furosemide for volume overload and edema in heart failure involves ensuring patients are on target doses of ACE i…
Recent evidence suggests coronary stents don't improve chest pain more than optimal medications in patients with stable coronary artery disease. …
As a cardiovascular pharmacist, you will often hear debates on the optimal duration of dual antiplatelet therapy (DAPT) after stent placement in acut…
Triple Whammy Effect (NSAIDs, Diuretics, and ACEIs/ARBs) Acute kidney injury (AKI) risk increases when combining NSAIDs with diuretics and ACE inhi…
Introduction A common scenario leading to kidney injury occurs when patients on ACE inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) …
Recent interest in colchicine ( Lodoco ) emerges from its potential to reduce cardiovascular (CV) risk due to its anti-inflammatory properties. Origi…
Managing mild hypertension (systolic BP 140-159 mmHg, diastolic BP 90-99 mmHg) is a topic of ongoing debate. Recent data indicates that for every 128…
As cardiovascular pharmacists, the ongoing debate regarding the necessity of aiming for specific low-density lipoprotein (LDL) goals is crucial. Trad…
All NSAIDs carry a boxed warning for increased cardiovascular (CV) events. However, naproxen, celecoxib, and probably ibuprofen are associated with l…
As a cardiovascular pharmacist, questions about managing chronic hypertension in pregnancy are increasing. Factors like maternal age and obesity cont…
As a clinical pharmacy specialist, you will often get questions about managing heart failure with preserved ejection fraction (HFpEF) based on new gu…
As a clinical pharmacist, you're likely aware that up to 30% of statin patients experience muscle pain, cramps, or weakness, typically in the lar…
As a clinical pharmacist, managing dual antiplatelet therapy (DAPT) around surgery in patients with recent coronary stents is crucial. According to A…